Mashup Score:212
JAMA NetworkAnalysis of COVID-19–Related Croup and SARS-CoV-2 Variant Predominance in the US - 1 month
Mashup Score:212
Twitter Feed: Antonio Pagliuca
Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study...
-
RT @Lymphoma_Doc: The next step trial where we reduce/remove chemo based upon response: https://t.co/12HBOZRLmu - view on twitter
Objectives To quantify in absolute and relative terms how population-level COVID-19 death rates have changed in demographic and clinical subgroups. Design Retrospective cohort study...
-
Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18m adults in England medRxiv. vaccination in the IS patients is blunted. Prophylaxis needed to save lives https://t.co/wtczkCgN1Y - view on twitter
Mashup Score:2
www.nice.org.ukProject information | Tixagevimab–cilgavimab for preventing COVID-19 [ID6136] | Guidance | NICE - 2 weeks
Mashup Score:2
Tixagevimab–cilgavimab for preventing COVID-19...
-
Project info Tixagevimab–cilgavimab for preventing COVID-19 [ID6136] Guidance | NICE. Such an important decision. @BSBMTCT @AnthonyNolan @bloodcancer_uk @LeukaemiaCareUK @CureLeukaemia. Let’s get this over the line. https://t.co/pPtDXgkdU1 - view on twitter
Mashup Score:2
JAMA NetworkEvusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults - 3 weeks
Mashup Score:2
Tixagevimab plus cilgavimab, a SARS-CoV-2–neutralizing monoclonal antibody combination marketed as Evusheld, protected nonhospitalized individuals with mild to moderate COVID-19 symptoms from progressing to severe...
-
Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults https://t.co/bEN64NBbj1 via @JAMA_current part of @JAMANetwork. - view on twitter
PURPOSE Outcomes are poor in TP53-mutant (mTP53) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), even after allogeneic hematopoietic stem-cell transplant (HCT). Eprenetapopt (APR-246)...
-
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes | Journal of Clinical Oncology https://t.co/7iR2fx3F3i - view on twitter
Mashup Score:1
The BMJDavid Oliver: My personal pandemic experience is just one of many - 4 weeks
Mashup Score:1
I rarely write about my personal experiences, but practising medicine during the covid pandemic has finally given me the motivation. I’m just one of...
-
David Oliver: My personal pandemic experience is just one of many https://t.co/1289PGS1r7. So sad but so true. - view on twitter
Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised...
-
RT @drlennardlee: 2/x. Paper is available here. https://t.co/qAtV7pm8qb. Peer reviewed in a journal by @CDCgov and by @MarionKoopmans, Head… - view on twitter
Background: Estimates of immunity and severity for the SARS-CoV-2 omicron subvariant BA.5 are important to assess the public health impact associated with...
-
RT @EricTopol: First report on vaccine and clinical impact of BA.5 variant from Denmark nationwide study https://t.co/irVPdy47wW —good vacc… - view on twitter
Annual statistics on live births including countries of birth for non-UK-born mothers and...
-
RT @ONS: Latest data on births by parents’ country of birth, England and Wales in 2021 https://t.co/gqxiP6u4YM In 2021, 28.8% of live birt… - view on twitter
This cross-sectional study investigates the association of dominant SARS-CoV-2 variants with COVID-19–related...
RT @EricTopol: Hospitalizations for croup in children with Covid rose substantially with Omicron BA.1.1 https://t.co/3b9qQ0COxf @JAMANetwor… - view on twitter